Literature DB >> 8406794

Virulence of Bordetella bronchiseptica: role of adenylate cyclase-hemolysin.

P Gueirard1, N Guiso.   

Abstract

Bordetella bronchiseptica is a pathogen of laboratory, domestic, and wild animals and sometimes of humans. In the present study some characteristics of the virulence of B. bronchiseptica isolates of different origin were studied. All isolates had similar phenotypes, similar bacteriological characters, and synthesized adenylate cyclase-hemolysin, filamentous hemagglutinin and pertactin but not pertussis toxin. These isolates, however, differed in their ability to express dermonecrotic toxin and to cause a lethal infection, but no correlation was found with the human or animal origin of the isolates. The fact that the most virulent isolate did not express dermonecrotic toxin suggests that this toxin does not play an important role in the virulence of the bacteria in the murine model. After infection with virulent B. bronchiseptica a very early synthesis and a persistence of anti-adenylate cyclase-hemolysin and anti-filamentous hemagglutinin antibodies were observed in the sera of infected mice, suggesting a persistence of the bacteria or of its antigens. B. bronchiseptica adenylate cyclase-hemolysin was purified and was shown to be a major protective antigen against B. bronchiseptica infection. Furthermore, we showed that its immunological and protective properties were different from that of B. pertussis adenylate cyclase-hemolysin, confirming that Bordetella species are immunologically different.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406794      PMCID: PMC281126          DOI: 10.1128/iai.61.10.4072-4078.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Evaluation of Bordetella bronchiseptica vaccines in specific-pathogen-free piglets with bacterial cell surface antigens in enzyme-linked immunosorbent assay.

Authors:  P Novotny; M Kobisch; K Cownley; A P Chubb; J A Montaraz
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

3.  A simple chemically defined medium for the production of phase I Bordetella pertussis.

Authors:  D W Stainer; M J Scholte
Journal:  J Gen Microbiol       Date:  1970-10

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Morphology of cells and hemagglutinogens of Bordetella species: resolution of substructural units in fimbriae of Bordetella pertussis.

Authors:  J Blom; G A Hansen; F M Poulsen
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

6.  Adenylate cyclase activity of Bordetella organisms. I. Its production in liquid medium.

Authors:  M Endoh; T Takezawa; Y Nakase
Journal:  Microbiol Immunol       Date:  1980       Impact factor: 1.955

Review 7.  Biology of Bordetella bronchiseptica.

Authors:  R A Goodnow
Journal:  Microbiol Rev       Date:  1980-12

8.  Phagocyte impotence caused by an invasive bacterial adenylate cyclase.

Authors:  D L Confer; J W Eaton
Journal:  Science       Date:  1982-09-03       Impact factor: 47.728

9.  Pathogenesis of canine bordetellosis.

Authors:  D A Bemis; H A Greisen; M J Appel
Journal:  J Infect Dis       Date:  1977-05       Impact factor: 5.226

10.  Genetic diversity and relationships in populations of Bordetella spp.

Authors:  J M Musser; E L Hewlett; M S Peppler; R K Selander
Journal:  J Bacteriol       Date:  1986-04       Impact factor: 3.490

View more
  25 in total

1.  Bordetella bronchiseptica persists in the nasal cavities of mice and triggers early delivery of dendritic cells in the lymph nodes draining the lower and upper respiratory tract.

Authors:  Pascale Gueirard; Patrick Ave; Anne-Marie Balazuc; Sabine Thiberge; Michel Huerre; Genevieve Milon; Nicole Guiso
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

2.  Bordetella pertussis risA, but not risS, is required for maximal expression of Bvg-repressed genes.

Authors:  Trevor H Stenson; Andrew G Allen; Jehan A Al-Meer; Duncan Maskell; Mark S Peppler
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Replacement of adenylate cyclase toxin in a lineage of Bordetella bronchiseptica.

Authors:  Anne M Buboltz; Tracy L Nicholson; Mylisa R Parette; Sara E Hester; Julian Parkhill; Eric T Harvill
Journal:  J Bacteriol       Date:  2008-06-13       Impact factor: 3.490

4.  Membrane Vesicles Derived from Bordetella bronchiseptica: Active Constituent of a New Vaccine against Infections Caused by This Pathogen.

Authors:  D Bottero; M E Zurita; M E Gaillard; E Bartel; C Vercellini; D Hozbor
Journal:  Appl Environ Microbiol       Date:  2018-01-31       Impact factor: 4.792

5.  Role of the type III secretion system in a hypervirulent lineage of Bordetella bronchiseptica.

Authors:  Anne M Buboltz; Tracy L Nicholson; Laura S Weyrich; Eric T Harvill
Journal:  Infect Immun       Date:  2009-07-13       Impact factor: 3.441

6.  Phase variation affects long-term survival of Bordetella bronchiseptica in professional phagocytes.

Authors:  A Banemann; R Gross
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

7.  Invasion and intracellular survival of Bordetella bronchiseptica in mouse dendritic cells.

Authors:  C A Guzman; M Rohde; M Bock; K N Timmis
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

8.  BvgAS-mediated signal transduction: analysis of phase-locked regulatory mutants of Bordetella bronchiseptica in a rabbit model.

Authors:  P A Cotter; J F Miller
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  The C-terminal domain is essential for protective activity of the Bordetella pertussis adenylate cyclase-hemolysin.

Authors:  F Betsou; P Sebo; N Guiso
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

10.  BvgAS is sufficient for activation of the Bordetella pertussis ptx locus in Escherichia coli.

Authors:  M A Uhl; J F Miller
Journal:  J Bacteriol       Date:  1995-11       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.